{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:28:38Z","timestamp":1786739318202,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"\n Background and Aims:<\/jats:title>\n \n Transdermal opioids are newer modality in use for the control of postoperative pain, because of its noninvasiveness, longer duration of action, sustained blood levels, and with minimal side effects. The study was aimed to evaluate the efficacy of analgesia of buprenorphine patch 10, 20 \u03bcg\u00b7h\n -1<\/jats:sup>\n and fentanyl patch 25 \u03bcg\u00b7h\n -1<\/jats:sup>\n for relief of pain in the postoperative period in patients undergoing arthroscopic lower limb surgeries.\n <\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n It was a randomized, double-blinded, prospective study in which adult patients undergoing lower limb arthroscopic surgery were randomly segregated into three groups. In Group 1 (fentanyl patch 25 \u03bcg\u00b7h\n -1<\/jats:sup>\n ), Group 2 (buprenorphine patch 10 \u03bcg\u00b7h\n -1<\/jats:sup>\n ), and Group 3 (buprenorphine patch 20 \u03bcg\u00b7h\n -1<\/jats:sup>\n ), transdermal patches were applied 12 h prior to surgery. Mean NRS score, total rescue analgesic requirement, drug-related adverse effects, and hemodynamic status were evaluated till 72 h in the postoperative period.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Out of 175 screened patients, 150 patients were finally analyzed. Baseline characteristics were the same among all the three groups. Median NRS score was lowest in Group 3 [\n P<\/jats:italic>\n value < 0.05 at 2, 4, 8, 12, and 24 h after surgery (Kruskal Wallis test). The total consumption of postoperative rescue analgesic diclofenac was the lowest in Group 3 as compared to other groups without any significant increase in adverse events.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n \n In arthroscopic lower limb surgery, buprenorphine patch (20 \u03bcg\u00b7h\n -1<\/jats:sup>\n ) applied 12 h prior to surgery is an effective postoperative analgesic and it is not associated with any significant adverse effects.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/joacp.joacp_405_20","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T14:48:45Z","timestamp":1626360525000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl patch in management of postoperative pain after arthroscopic lower limb surgery"],"prefix":"10.4103","volume":"37","author":[{"given":"Hariom","family":"Khandelwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishith","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Parag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat Bhushan","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20240828","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-019-00146-3","article-title":"Non-opioid perioperative pain strategies for the clinician: A narrative review","volume":"9","author":"Kaye","year":"2020","journal-title":"Pain Ther"},{"key":"R2-21-20240828","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mcna.2015.08.005","article-title":"The acute to chronic pain transition: Can chronic pain be prevented?","volume":"100","author":"Pozek","year":"2016","journal-title":"Med Clin North Am"},{"key":"R3-21-20240828","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2147\/JPR.S128655","article-title":"Evidence and consensus recommendations for the pharmacological management of pain in India","volume":"10","author":"Dureja","year":"2017","journal-title":"J Pain Res"},{"key":"R4-21-20240828","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R5-21-20240828","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R6-21-20240828","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/joacp.JOACP_63_16","article-title":"Newer drug delivery systems in anesthesia","volume":"33","author":"Dave","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"R7-21-20240828","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40265-017-0727-z","article-title":"Fentanyl formulations in the management of pain: An update","volume":"77","author":"Schug","year":"2017","journal-title":"Drugs"},{"key":"R8-21-20240828","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/ija.IJA_208_16","article-title":"Safety and efficacy of transdermal buprenorphine versus oral tramadol for the treatment of post-operative pain following surgery for fracture neck of femur: A prospective, randomised clinical study","volume":"61","author":"Desai","year":"2017","journal-title":"Indian J Anaesth"},{"key":"R9-21-20240828","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.arth.2020.02.015","article-title":"Efficacy and safety of buprenorphine transdermal patch for immediate postoperative analgesia after total knee arthroplasty surgery","volume":"35","author":"Londhe","year":"2020","journal-title":"J Arthroplasty"},{"key":"R10-21-20240828","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ijpn.ijpn_4_18","article-title":"Comparison of efficacy and safety of transdermal buprenorphine patch applied 48 versus 72 hours preoperatively in providing adequate postoperative analgesia following major abdominal surgeries","volume":"32","author":"Kadapamannil","year":"2018","journal-title":"Indian J Pain"},{"key":"R11-21-20240828","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00044011-200828050-00005","article-title":"Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in japanese patients with cancer pain","volume":"28","author":"Miyazaki","year":"2008","journal-title":"Clin Drug Investig"},{"key":"R12-21-20240828","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11208360-000000000-00000","article-title":"Buprenorphine 5, 10 and 20 \u03bcg\/h transdermal patch: A guide to its use in chronic non-malignant pain","volume":"26","author":"Plosker","year":"2012","journal-title":"CNS Drugs"},{"key":"R13-21-20240828","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2165\/00003495-200363190-00003","article-title":"Transdermal buprenorphine","volume":"63","author":"Evans","year":"2003","journal-title":"Drugs"},{"key":"R14-21-20240828","first-page":"871","article-title":"Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients","volume":"79","author":"Canneti","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"R15-21-20240828","first-page":"UC01","article-title":"Comparison between transdermal buprenorphine and transdermal fentanyl for postoperative pain relief after major abdominal surgeries","volume":"9","author":"Arshad","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R16-21-20240828","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2106\/JBJS.19.01035","article-title":"Analgesia in total knee arthroplasty: Current pain control modalities and outcomes","volume":"102","author":"Summers","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"R17-21-20240828","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2106\/JBJS.RVW.18.00023","article-title":"Total hip and knee arthroplasty perioperative pain management: What should be in the cocktail","volume":"6","author":"Pepper","year":"2018","journal-title":"JBJS Rev"},{"key":"R18-21-20240828","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1185\/03007995.2015.1058251","article-title":"Effect of nefopam- versus fentanyl-based patient-controlled analgesia on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery: A prospective double-blind randomized controlled trial","volume":"31","author":"Oh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"R19-21-20240828","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bjan.2020.04.004","article-title":"Uso da buprenorfina transd\u00e9rmica na dor aguda p\u00f3s-operat\u00f3ria: Revis\u00e3o sistem\u00e1tica [Transdermal buprenorphine for acute postoperative pain: A systematic review]","volume":"70","author":"Machado","year":"2020","journal-title":"Rev Bras Anestesiol"},{"key":"R20-21-20240828","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"R21-21-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/papr.12432","article-title":"Patient-controlled fentanyl iontophoretic transdermal system improved postoperative mobility compared to intravenous patient-controlled analgesia morphine: A pooled analysis of randomized, controlled trials","volume":"17","author":"Oliashirazi","year":"2017","journal-title":"Pain Pract"},{"key":"R22-21-20240828","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jpm.2007.0200","article-title":"Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature","volume":"11","author":"Tassinari","year":"2008","journal-title":"J Palliat Med"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_405_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:27:56Z","timestamp":1786735676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.JOACP_405_20"}},"subtitle":["A randomized controlled trial"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/joacp.joacp_405_20","relation":{},"ISSN":["0970-9185"],"issn-type":[{"value":"0970-9185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}